Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
| Period | Ac-225 trials supported (printed floor) |
|---|---|
| Q3 FY2026 | 15 |
| Period | GLP-1 revenue growth (printed floor) | Contribution to total revenue growth (pts) |
|---|---|---|
| Q3 FY2026 | 30 | 6 |
| Period | Printed growth |
|---|---|
| Q3 FY2026 OptiFreight | Nearly 20% |
| Segment | Revenue ($M) | Segment profit ($M) | Segment profit margin (%) |
|---|---|---|---|
| Pharmaceutical and Specialty Solutions | 56,111 | 784 | 1.4 |
| Global Medical Products and Distribution | 3,148 | 25 | 0.79 |
| Other (nuclear, at-home, OptiFreight) | 1,706 | 179 | 10.49 |
| Period | Printed growth |
|---|---|
| Q3 FY2026 | Specialty more than 20% |
| Period | Printed growth |
|---|---|
| Q3 FY2026 Theranostics | More than 30% |